We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
Cap. Flow
-$1.32B
Cap. Flow %
-31.23%
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
3.6 quarters
Top 10 Avg Time Held Equity + Options
0.7 quarters
Top 20 Avg Time Held Equity + Options
0.8 quarters
Avg Time Held Equity only
3.7 quarters
Top 10 Avg Time Held Equity only
0.7 quarters
Top 20 Avg Time Held Equity only
0.8 quarters

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
STOR
STORE Capital Corporation
STOR
+$414M
2
LHCG
LHC Group LLC
LHCG
+$211M
3
ATVI
Activision Blizzard
ATVI
+$196M
4
SGFY
Signify Health, Inc.
SGFY
+$161M
5
ONEM
1Life Healthcare
ONEM
+$141M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.3%
3 Technology 18.64%
4 Miscellaneous 15.12%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
MTH icon
201
Meritage Homes
MTH
$3.83B
$2.74M 0.07%
47,006
-72,694
-61% -$3.91M
2022 Q2
3 quarters
VSAC icon
202
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$2.74M 0.06%
259,942
– –
2022 Q1
4 quarters
HR icon
203
Healthcare Realty
HR
$5.88B
$2.69M 0.06%
+138,944
New +$2.8M
2023 Q1
0 quarters
XPEV icon
204
XPeng
XPEV
$9.48B
$2.68M 0.06%
+241,364
New +$2.33M
2023 Q1
0 quarters
HALO icon
205
Halozyme
HALO
$12.5B
$2.67M 0.06%
69,920
+12,583
+22% +$590K
2022 Q1
4 quarters
PTCT icon
206
PTC Therapeutics
PTCT
$5.4B
$2.65M 0.06%
54,763
+22,108
+68% +$1.01M
2022 Q4
1 quarter
GKOS icon
207
Glaukos
GKOS
$9.77B
$2.64M 0.06%
52,738
+6,511
+14% +$316K
2022 Q1
4 quarters
NFNT
208
DELISTED
Infinite Acquisition Corp.
NFNT
$2.64M 0.06%
253,101
-217,669
-46% -$2.25M
2022 Q1
4 quarters
SWTX icon
209
DELISTED
SpringWorks Therapeutics
SWTX
$2.56M 0.06%
99,580
-12,035
-11% -$352K
2022 Q1
4 quarters
TSM icon
210
TSMC
TSM
$2.35T
$2.56M 0.06%
27,547
-43,398
-61% -$3.9M
2022 Q1
4 quarters
GOGN
211
DELISTED
GoGreen Investments Corporation
GOGN
$2.52M 0.06%
238,548
-75
-0% -$785
2021 Q4
5 quarters
ABBV icon
212
AbbVie
ABBV
$489B
$2.52M 0.06%
15,782
-1,320
-8% -$202K
2022 Q3
2 quarters
ANAB icon
213
AnaptysBio
ANAB
$1.37B
$2.51M 0.06%
115,479
+18,499
+19% +$450K
2022 Q1
4 quarters
DSAQ icon
214
DELISTED
Direct Selling Acquisition Corp.
DSAQ
$2.5M 0.06%
238,161
– –
2021 Q4
5 quarters
PTGX icon
215
Protagonist Therapeutics
PTGX
$9.3B
$2.49M 0.06%
108,473
-168,000
-61% -$2.82M
2022 Q1
4 quarters
FEXD icon
216
DELISTED
Fintech Ecosystem Development Corp. Class A Common Stock
FEXD
$2.49M 0.06%
236,311
– –
2022 Q1
4 quarters
RCFA icon
217
DELISTED
Perception Capital Corp. IV
RCFA
$2.47M 0.06%
236,311
– –
2022 Q1
4 quarters
GTAC
218
DELISTED
Global Technology Acquisition Corp. I Class A Ordinary Shares
GTAC
$2.47M 0.06%
236,311
– –
2022 Q1
4 quarters
SZZL icon
219
DELISTED
Sizzle Acquisition Corp. Common stock
SZZL
$2.47M 0.06%
236,311
– –
2022 Q1
4 quarters
CCTS icon
220
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
$2.47M 0.06%
236,311
– –
2022 Q1
4 quarters
AVAC
221
DELISTED
Avalon Acquisition Inc. Class A Common Stock
AVAC
$2.46M 0.06%
236,311
– –
2021 Q4
5 quarters
MSAI icon
222
MultiSensor AI
MSAI
$10.3M
$2.46M 0.06%
5,908
– –
2021 Q4
5 quarters
APMI icon
223
DELISTED
AxonPrime Infrastructure Acquisition Corporation Class A Common Stock
APMI
$2.46M 0.06%
236,311
– –
2021 Q4
5 quarters
MRT icon
224
Marti Technologies
MRT
$161M
$2.46M 0.06%
236,311
– –
2021 Q3
6 quarters
AXGN icon
225
Axogen
AXGN
$2.12B
$2.45M 0.06%
259,214
+32,344
+14% +$296K
2022 Q1
4 quarters
7 8
9
10 11

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
  • UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.